Safety Study of PEGPH20 Given to Patients With Advanced Solid Tumors
Clinical trial NCT00834704 · COMPLETED
Trial details
- NCT number
- NCT00834704
- Sponsor
- Halozyme Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2012-06-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.